Panther Fusion® Paraflu Assay
A fully-automated approach to respiratory testing of parainfluenza 1, 2, 3 and 4 in one single assay.1
Panther Fusion Paraflu Assay
The Panther Fusion Paraflu assay is a multiplex real-time PCR (RT-PCR) in vitro diagnostic test for the rapid and qualitative detection and differentiation of parainfluenza 1 virus (HPIV-1), parainfluenza 2 virus (HPIV-2), parainfluenza 3 virus (HPIV-3) and parainfluenza 4 virus (HPIV-4). Diagnose samples from nasopharyngeal (NP) swab specimens obtained from individuals exhibiting signs and symptoms of a respiratory tract infection.1
Increase Efficiency & Reduce Costs
Personalise your patient testing by running Panther Fusion Paraflu assay alone or in conjunction with other Panther Fusion respiratory assays.1
Protecting Children
HPIVs commonly infect infants and young children. HPIV-1 and HPIV-2 both cause croup, with HPIV-1 most often identified as the cause in children. Both can also cause upper and lower respiratory illness and cold-like symptoms.1,2
Differentiate Results
Four targets in one assay, including HPIV-3, associated with bronchiolitis, bronchitis, and pneumonia, and HPIV-4 which may cause mild to severe respiratory tract illnesses.1
Testing Variety
The assay can be run alongside current infectious disease, women’s health and virology assays, enabling laboratories to unlock the free capacity on their existing Panther Systems.
Simplify & Scale the Future of Diagnostics
The Panther Fusion Paraflu Assay is part of the Hologic Molecular Scalable Solution, a portfolio combining a broad, high-performing assay menu with high-throughput automation. Designed to flexibly scale to meet your needs, from a single patient result to population-level screening.
Be Prepared for the Winter Respiratory Season
The Panther Fusion assay shows excellent clinical performance.1
100% Sensitivity
100% specificity Parainfluenza 1
100% Sensitivity
100% specificity Parainfluenza 2
100% Sensitivity
99.6% specificity Parainfluenza 3
98.1% Sensitivity
100% specificity Parainfluenza 4
Right Patient. Right Test. Right Time.3
- From true on-demand testing to high-throughput
- No sample batch constraints, prioritise urgent samples
- First results in 2.4 hours
- Run multiple assays from a single specimen tube at the same time
- Single dose, ready-to-use-assay reagent cartridge
- Long onboard stability of fluids and reagents
Verified Sample Collection
The Panther Fusion Paraflu assay is validated for nasopharyngeal swabs in viral transport medium and universal transport medium.1
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
Insights
- Panther Fusion Paraflu assay [package insert]. AW-23708-001 Rev 001. San Diego, CA: Hologic, Inc.; 2022.
- Oh DY, Biere B, Grenz M, Wolff T, Schweiger B, Dürrwald R, Reiche J. Virological Surveillance and Molecular Characterization of Human Parainfluenzavirus Infection in Children with Acute Respiratory Illness: Germany, 2015-2019. Microorganisms. 2021 Jul 14;9(7):1508. doi: 10.3390/microorganisms9071508. PMID: 34361941; PMCID: PMC8307145
- Panther/Panther Fusion System Operator´s Manual. AW-26055-001 Rev 001, San Diego, CA: Hologic Inc.; 2022.
Safety Data Sheets
Package Inserts
2797
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
Notified Body number wherever applicable
EC Representative Information wherever applicable